Science Market Update

MU Receives $3M for Hepatitis B Treatment Research

Posted by Emily Olson on Mon, Oct 10, 2016

Dr. Stefan Sarafianos, a professor of Molecular Microbiology and Immunology at the University of Missouri, was recently awarded a research grant of $3 million from the National Institutes of Health to develop new drugs to treat Hepatitis B (HBV).

Read More

Tags: Missouri, University of Missouri, Drug Development, MO, NIH award, Midwest Region, MU, Hepatitis B, University of Missouri, Columbia

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!